Potential Effects of Electronic Nicotine Delivery System Flavor Regulations on African American Menthol Smokers
RVA Flavors
Effects of Electronic Nicotine Delivery System Flavor Regulations on Tobacco Behavior, Toxicity, and Abuse Liability Among African American Menthol Smokers (RVA Flavors)
2 other identifiers
interventional
71
1 country
1
Brief Summary
This study aims to better understand how the availability of electronic nicotine delivery system (aka electronic cigarettes) flavors (e.g., menthol, tobacco) impacts tobacco use behaviors, toxicant exposure, and abuse liability among African American menthol smokers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 20, 2021
CompletedFirst Posted
Study publicly available on registry
August 26, 2021
CompletedStudy Start
First participant enrolled
April 14, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2024
CompletedResults Posted
Study results publicly available
April 22, 2026
CompletedApril 22, 2026
April 1, 2026
2.5 years
August 20, 2021
October 25, 2025
April 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Average Daily Cigarette Use
Number of cigarettes used in the past day, collected via daily text survey, averaged over the past week
Randomization and Week 6
Carbon Monoxide Exposure
A biomarker of combusted cigarette use collected from exhaled breath.
Randomization and Week 6
Willingness to Substitute From Cigarettes to ENDS
CP-DPT involves participants making two hypothetical choices at once, for a series of price scenarios involving their own brand cigarettes and condition-specific ENDS. For example, participants are asked how many puffs of their Own Brand Cigarette AND how many puffs of a their conditions-specific ENDS they would purchase if each Own Brand Cigarette puff cost $0.00 (i.e., free) and each ENDS puff cost $0.10. The outcome of the task is the willingness to pay in USD for each ENDS puff.
Week 6
Study Arms (3)
Menthol+Tobacco
ACTIVE COMPARATORMenthol+Tobacco - where both menthol and tobacco flavored liquids for electronic nicotine delivery systems are available to choose from
Tobacco
EXPERIMENTALTobacco - where only tobacco flavored liquid is available for electronic nicotine delivery systems
Unflavored
EXPERIMENTALUnflavored - where only unflavored liquid is available for electronic nicotine delivery systems
Interventions
Participants are first instructed to smoke their usual brand of menthol cigarettes normally for the next 7 days and avoid using any other tobacco products. After this baseline week, participants are randomized to 1 of 3 ENDS flavor conditions, all contain 5% nicotine (Mentol+Tobacco, Tobacco, Unflavored) with equal probability and provided with a supply of their condition specific ENDS and asked to use it in place of their usual menthol cigarettes for the next 6 weeks.
Eligibility Criteria
You may qualify if:
- + years of age
- identify as Black/African American (single or multi-race)
- have used ≥5 cigarettes per day for ≥1 year
- biochemically confirmed cigarette smoking status
- regular cigarette brand is flavored to taste like menthol or mint
- ENDS use in the past 3 months
- report no intent to quit smoking in the next 6 months
- previous quit attempt using evidence-based method
- have a working mobile phone with a texting/data plan
- are willing receive phone calls/text messages and complete internet-based/online surveys related to the study.
- read and write in English
You may not qualify if:
- are unwilling to use ENDS as part of the trial
- unstable or significant medical condition in the past 12 months
- report any other illegal drug use in past 30 days
- report intent to become pregnant or current pregnancy/breastfeeding
- report any other condition that may affect participant safety or not allow them to fully participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Caroline Cobb, Associate Professor
- Organization
- Virginia Commonwealth University
Study Officials
- PRINCIPAL INVESTIGATOR
Andrew J Barnes, PhD
Virginia Commonwealth University
- PRINCIPAL INVESTIGATOR
Caroline O Cobb, PhD
Virginia Commonwealth University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 20, 2021
First Posted
August 26, 2021
Study Start
April 14, 2022
Primary Completion
October 15, 2024
Study Completion
October 15, 2024
Last Updated
April 22, 2026
Results First Posted
April 22, 2026
Record last verified: 2026-04